NYSEAMERICAN:XTNT - Xtant Medical Stock Price, News, Headlines & Rumors

Sign in or create an account to add this stock to your watchlist.
$6.0070 -0.03 (-0.50 %)
(As of 08/17/2018 11:45 AM ET)
Previous Close$6.04
Today's Range$6.0070 - $6.04
52-Week Range$3.96 - $11.50
Volume618 shs
Average Volume42,587 shs
Market Capitalization$140.58 million
P/E RatioN/A
Dividend YieldN/A
Beta0.19
Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Receive XTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for XTNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSEAMERICAN:XTNT
CUSIPN/A
Phone+1-406-3880480

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-43.03%
Return on EquityN/A
Return on Assets-25.99%

Miscellaneous

EmployeesN/A
Outstanding Shares13,150,000
Market Cap$140.58 million

Xtant Medical (NYSEAMERICAN:XTNT) Frequently Asked Questions

What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

When did Xtant Medical's stock split? How did Xtant Medical's stock split work?

Xtant Medical's stock reverse split before market open on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of Xtant Medical stock prior to the reverse split would have 8 shares after the split.

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) issued its earnings results on Tuesday, August, 7th. The medical device company reported ($0.38) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by $0.12. The medical device company had revenue of $18.74 million for the quarter. View Xtant Medical's Earnings History.

When is Xtant Medical's next earnings date?

Xtant Medical is scheduled to release their next quarterly earnings announcement on Tuesday, November, 20th 2018. View Earnings Estimates for Xtant Medical.

What price target have analysts set for XTNT?

1 brokerages have issued twelve-month target prices for Xtant Medical's stock. Their forecasts range from $10.00 to $10.00. On average, they expect Xtant Medical's share price to reach $10.00 in the next year. This suggests a possible upside of 66.5% from the stock's current price. View Analyst Price Targets for Xtant Medical.

What is the consensus analysts' recommendation for Xtant Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Xtant Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Xtant Medical.

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the folowing people:
  • Carl D. O'Connell, President, Chief Executive Officer (Age 53)
  • Darrel Lee Holmes, Chief Operating Officer (Age 62)
  • Gregory Juda Ph.D., Chief Scientific Officer (Age 39)
  • John K. Bakewell, Director (Age 55)
  • Michael Eggenberg, Director
  • Michael R. Mainelli Jr., Director (Age 55)
  • Robert E. McNamara, Director (Age 61)
  • Jeffrey J. Peters, Director

Has Xtant Medical been receiving favorable news coverage?

Media headlines about XTNT stock have been trending somewhat positive on Friday, according to Accern Sentiment. Accern identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Xtant Medical earned a daily sentiment score of 0.07 on Accern's scale. They also gave media stories about the medical device company an impact score of 47.03 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future. View Recent Headlines for Xtant Medical.

How do I buy shares of Xtant Medical?

Shares of XTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Xtant Medical's stock price today?

One share of XTNT stock can currently be purchased for approximately $6.0070.

How big of a company is Xtant Medical?

Xtant Medical has a market capitalization of $140.58 million.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The medical device company can be reached via phone at +1-406-3880480.


MarketBeat Community Rating for Xtant Medical (NYSEAMERICAN XTNT)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  107
MarketBeat's community ratings are surveys of what our community members think about Xtant Medical and other stocks. Vote "Outperform" if you believe XTNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XTNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.